Connection

Nadia Aspromonte to Drug Design

Back to Details
This is a "connection" page, showing publications Nadia Aspromonte has written about Drug Design.
Nadia Aspromonte
Connection Strength
0.078
Drug Design
  1. Clinical potential relevance of metabolic properties of SGLT2 inhibitors in patients with heart failure. Expert Opin Drug Metab Toxicol. 2018 Dec; 14(12):1273-1285.
    View in: PubMed
    Score: 0.078
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.